Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06705075 · ClinicalTrials.gov registry record · Phase 2
Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE
A Phase 2 study of Uterine Fibroid, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT06705075 is a Phase 2 study of Uterine Fibroid that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 80 participants, below the 306-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06705075, a Phase 2 study of Uterine Fibroid, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the result of UAE procedures. Also, this study will evaluate uterine fibroid pressures using SHAPE, comparing the results with normal myometrium tissue in order to determine its characteristics and tissue differences, which we believe will lead to the development of a new biomarker for the diagnosis and treatment of uterine fibroids.
Conditions Studied
Interventions
- DRUG Perfluten
Study Locations (1)
Pennsylvania
- Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2026-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06705075
The ClinicalTrials.gov registry entry for NCT06705075 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 306-participant average among 5 other Uterine Fibroid trials with a reported enrollment target (74% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uterine Fibroid appearing as the primary indexed condition, and to 1 intervention - of which Perfluten is the first listed.
NCT06705075 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06705075 about?
NCT06705075 is a clinical study titled "Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE". This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the resu...
What is the current status of trial NCT06705075?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2025-01-27. Estimated completion is 2026-09-30.
What conditions does trial NCT06705075 study?
This clinical trial studies the following conditions: Uterine Fibroid.
What interventions are being tested in trial NCT06705075?
The interventions under investigation include: Perfluten (DRUG).
Who is sponsoring clinical trial NCT06705075?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06705075 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids
RECRUITING
-
Life Study: Lifestyle Intervention in Fibroid Elimination
ACTIVE NOT RECRUITING · NA
-
Implementation of Uterine Fibroid Option Grid Patient Decision Aids Across Five Organizational Settings
COMPLETED · NA
-
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
COMPLETED · Phase 3
-
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.